The observed safety findings and overall tolerability in patients with T2DM are consistent with those in previously reported studies in patients with cryopyrin-associated periodic syndrome, gouty arthritis and systemic juvenile idiopathic arthritis[21-23]. Here, NLRP3 is linked to systemic-onset juvenile idiopathic arthritis.